Literature DB >> 10390422

No association between atopy/asthma and the ILe50Val polymorphism of IL-4 receptor.

E Noguchi1, M Shibasaki, T Arinami, K Takeda, Y Yokouchi, K Kobayashi, N Imoto, S Nakahara, A Matsui, H Hamaguchi.   

Abstract

Susceptibility to atopic diseases is known to involve genetic factors. The interleukin-4 (IL-4) receptor- alpha gene (IL4R) reportedly is involved in the development of atopy. A recent study has shown the Ile50 allele of a polymorphism (Ile50Val) of IL4R to be associated with atopy. The objective of this study was to replicate this association and confirm the possible role of the Ile50Val polymorphism of IL4R in the etiology of atopic asthma in a Japanese population. We conducted a transmission disequilibrium test in 86 families identified through asthmatic children. A case-control study was also carried out using both atopic and control subjects. The IL4R Ile50Val polymorphism was genotyped by a PCR-restriction fragment length polymorphism method using an intronic upstream primer. The IL4R Ile50 allele was not preferentially transmitted to atopy- or to asthma-affected children. Neither the Ile50 allele nor the Ile50/Ile50 genotype was more prevalent in the atopic subjects than in the control subjects. Our findings indicate that the Ile50Val polymorphism of IL4R does not play a substantial role in genetic predisposition for the etiology of atopy or asthma in this Japanese population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390422     DOI: 10.1164/ajrccm.160.1.9807130

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Effects of common atopy-associated amino acid substitutions in the IL-4 receptor alpha chain on IL-4 induced phenotypes.

Authors:  Izolda Franjkovic; Andre Gessner; Inke König; Karin Kissel; Anette Bohnert; Anne Hartung; Astrid Ohly; Andreas Ziegler; Holger Hackstein; Gregor Bein
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

2.  An atopy-associated polymorphism in the ectodomain of the IL-4R(alpha) chain (V50) regulates the persistence of STAT6 phosphorylation.

Authors:  Andrew Q Ford; Nicola M Heller; Linda Stephenson; Mark R Boothby; Achsah D Keegan
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

3.  Polymorphisms of interleukin (IL)-4 receptor alpha and signal transducer and activator of transcription-6 (Stat6) are associated with increased IL-4Ralpha-Stat6 signalling in lymphocytes and elevated serum IgE in patients with Graves' disease.

Authors:  K Yabiku; M Hayashi; I Komiya; T Yamada; Y Kinjo; Y Ohshiro; T Kouki; N Takasu
Journal:  Clin Exp Immunol       Date:  2007-03-15       Impact factor: 4.330

Review 4.  Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis.

Authors:  Alan P Knutsen; Raymond G Slavin
Journal:  Clin Dev Immunol       Date:  2011-04-05

5.  Immunopathology and immunogenetics of allergic bronchopulmonary aspergillosis.

Authors:  Alan P Knutsen
Journal:  J Allergy (Cairo)       Date:  2011-09-28

Review 6.  Interactions between genes and environmental factors in asthma and atopy: new developments.

Authors:  Claudia Sengler; Susanne Lau; Ulrich Wahn; Renate Nickel
Journal:  Respir Res       Date:  2001-10-31

7.  Preliminary analysis of single-nucleotide polymorphisms in IL-10, IL-4, and IL-4Rα genes and profile of circulating cytokines in patients with gastric Cancer.

Authors:  Denny Miley Cárdenas; Angie Carolina Sánchez; Daris Angélica Rosas; Esmeralda Rivero; Massiel Dayana Paparoni; Mildred Andreína Cruz; Yeicy Paola Suárez; Nestor Fabián Galvis
Journal:  BMC Gastroenterol       Date:  2018-12-10       Impact factor: 3.067

Review 8.  Association studies for asthma and atopic diseases: a comprehensive review of the literature.

Authors:  Sabine Hoffjan; Dan Nicolae; Carole Ober
Journal:  Respir Res       Date:  2003-12-04

9.  Association between interleukin-4 receptor α chain (IL4RA) I50V and Q551R polymorphisms and asthma risk: an update meta-analysis.

Authors:  Wei Nie; Yuansheng Zang; Jiquan Chen; Qingyu Xiu
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.